Connect with us

Business

Tetra Bio-Pharma Inc. (OTCMKTS: TBPMF) Obtains an Approval of the Proposed Protocol Modifications to Accelerate the REBORN Study

Published

on

Clinical trials are an essential component of any drug discovery and development program. Innovative research initiatives are the cornerstone upon which the success of the trials is built to deliver quality. Tetra Bio-Pharma Inc. (OTCMKTS: TBPMF) has made history using evidence-based scientific approaches, which have produced a pipeline of cannabinoid-based drug products for a range of medical conditions. And having given priority to patient’s demands, the company focuses on providing rigorous, scientific, safe, and validated data for use by the biopharma industry. 

In cannabinoid-derived drug discovery and development leadership, the company can now carry out the proposed protocol amendments, which will allow supplementary immediate-release oral opioids. They will be uses as comparators in the REBORN1© study. The approval by the Central Ethics Committee opens the enlistment of cancer patients with breakthrough pain. However, they should have had treatment with either oral morphine sulfate immediate release, oral oxycodone immediate release, or oral hydromorphone immediate release. The previous comparison was between QIXLEEF™ and oral morphine sulphate. 

Making QIXLEEF Become an Alternative Prescription Therapy to Opioids

The primary aim of Tetra Bio-Pharma is to bring to the industry novel prescription drugs and treatments to patients and their healthcare providers. Hence, the approval by the DEA would not have come at a better time than now. QIXLEEF is inhaled proprietary drug formulation and has a fixed ratio of THC and CBD. It is inhaled through a Class II medical vaporizer.

Expressing the company’s appreciation of the approval, the company’s CEO and CRO, Dr. Guy Chamberland, said, “The amended protocol allows QIXLEEF™ to be studied against three types of immediate-release oral opioids instead of just one. It will facilitate the recruitment of patients who can benefit from QIXLEEF….” 

In other news, it is worth bringing out the resignation of the company’s Chief Financial OfficerJean-François Boily as from July 16th, 2021. He had served in this position for nine months. Meanwhile, an executive search is underway to identify his replacement, but the company will in the meantime use its internal finance team and also retain the services of a consultant to serve as CFO. This will ensure the flow of financial reporting obligations.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

FEATURED STORIES

Business5 hours ago

The Tinley Beverage Company Inc. (OTCMKTS: TNYBF) Signs Agreement with BevCanna Enterprises For Canadian Version of Tinely’s Tonics

Post Views: 12 The Tinley Beverage Company Inc. (OTCMKTS: TNYBF) has entered an agreement with BevCanna Enterprises for the production...

Business5 hours ago

TILT Holdings Inc. (OTCMKTS: TLLTF) Expands relationship with Old Pal and Upgrades Listing of Shares to NEO Exchange

Post Views: 29 TILT Holdings Inc. (OTCMKTS: TLLTF) has announced an exclusive deal for producing, packaging, and distributing various Old...

Business5 hours ago

Harvest Health & Recreation Inc. (OTCMKTS: HRVSF) Receives Approval For Trulieve Transaction And Enters leaseback Agreement with IIP

Post Views: 23 Harvest Health & Recreation Inc. (OTCMKTS: HRVSF) has announced that it has received the final order from...

Business6 hours ago

Can B Corp (OTCMKTS: CANB) Announce Acquisition of Music City Botanicals LLC and TWS Pharma

Post Views: 10 Can B Corp (OTCMKTS: CANB) has announced the acquisition of Music City Botanicals LLC’s assets that include...

Business1 day ago

Cresco Labs Inc. (OTCMKTS: CRLBF) Opens Ninth Sunnyside Store in Florida and Enters Agreement to Acquire Blaire Wellness LLC

Post Views: 10 Cresco Labs Inc. (OTCMKTS: CRLBF) has opened its first Sunnyside store in Fort Lauderdale, Florida. The Sunnyside...

Business1 day ago

CordovaCann Corp (OTCMKTS: LVRLF) Continues Expanding Its Star Buds Cannabis Co Stores

Post Views: 37 CordovaCann Corp (OTCMKTS: LVRLF) has opened its 8th Star Buds Cannabis Co. branded retail outlet in Canada...